Fradafiban. BIBU 52, BIBU 52 ZW.
D000818:Animals; D001713:Biphenyl Compounds / Q000494:pharmacology / Q000627:therapeutic use*; D002144:Callithrix; D005340:Fibrinogen / Q000037:antagonists & inhibitors*; D006168:Guinea Pigs; D006801:Humans; D066298:In Vitro Techniques; D017202:Myocardial Ischemia / Q000188:drug therapy; D010975:Platelet Aggregation Inhibitors / Q000494:pharmacology / Q000627:therapeutic use*; D019039:Platelet Glycoprotein GPIIb-IIIa Complex / Q000037:antagonists & inhibitors*; D011759:Pyrrolidines / Q000494:pharmacology / Q000627:therapeutic use*; D013552:Swine; D013927:Thrombosis / Q000188:drug therapy*
D001713:Biphenyl Compounds; D010975:Platelet Aggregation Inhibitors; D019039:Platelet Glycoprotein GPIIb-IIIa Complex; D011759:Pyrrolidines; D005340:Fibrinogen; C107917:fradafiban